scispace - formally typeset
D

Dieter Kunz

Researcher at Charité

Publications -  101
Citations -  6335

Dieter Kunz is an academic researcher from Charité. The author has contributed to research in topics: Circadian rhythm & Melatonin. The author has an hindex of 43, co-authored 92 publications receiving 5505 citations. Previous affiliations of Dieter Kunz include Humboldt University of Berlin & University of Basel.

Papers
More filters
Journal ArticleDOI

Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study

TL;DR: In a prospective multicentre study involving 1280 patients with idiopathic RBD, Postuma et al. test the predictive power of 21 prodromal markers of neurodegeneration, providing a template for planning neuroprotective trials.
Journal ArticleDOI

Association of a functional BDNF polymorphism and anxiety-related personality traits

TL;DR: The hypothesis that anxiety- and depression-related personality traits are associated with the BDNF polymorphism although the explained variance is low is supported.
Journal ArticleDOI

An E-health solution for automatic sleep classification according to Rechtschaffen and Kales: validation study of the Somnolyzer 24 x 7 utilizing the Siesta database.

TL;DR: The development and optimization of an automatic classification system that is based on one central EEG channel, two EOG channels and one chin EMG channel and proved the high reliability and validity of the Somnolyzer 24 × 7 and demonstrated its applicability in clinical routine and sleep studies.
Journal ArticleDOI

Molecular insights into human daily behavior

TL;DR: It is concluded that human chronotype may be influenced not only by the period length of the circadian oscillator, but also by cellular components that affect its amplitude and phase.
Journal ArticleDOI

A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.

TL;DR: It is confirmed that exogenous melatonin improves RBD and the data suggest that melatonin might be a second useful agent besides clonazepam in the treatment of RBD.